A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto

  • When Samir Ounzian left London a decade ago to study a little-understood branch of the genome at a Swiss lab, he wasn’t sure what he would find. Known as long-non-coding RNA, these sections were translated into looping rings of RNA — hence the name — but didn’t actually translate into proteins, and no one was quite sure how many there were or precisely what they were doing.